[PDF][PDF] Predicting appropriate therapies and mortality in implantable cardioverter defibrillator recipients: a work in progress
RG Trohman - POLISH ARCHIVES OF INTERNAL MEDICINE …, 2019 - academia.edu
9 Ruwald MH, Solomon SD, Foster E, et al. Left ventricular ejection fraction normalization in
cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes …
cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes …
Determinants of patient survival rate after implantation of a cardioverter− defibrillator without resynchronisation capability
J Lelakowski, J Piekarz, A Rydlewska… - Polish Heart …, 2012 - journals.viamedica.pl
Background: Proper selection of patients at high risk for sudden cardiac death (SCD) and
increasing use of implantable cardioverter-defibrillators (ICD) may contribute to improved …
increasing use of implantable cardioverter-defibrillators (ICD) may contribute to improved …
Selection and outcome of implantable cardioverter‐defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the …
J Köbe, K Willy, J Senges, M Hochadel… - Journal of …, 2022 - Wiley Online Library
Background Registry data add important information to randomized controlled trials (RCT)
on real‐life aspects of implantable cardioverter‐defibrillator (ICD) patients with and without …
on real‐life aspects of implantable cardioverter‐defibrillator (ICD) patients with and without …
Outcome of primary prevention implantable cardioverter defibrillator therapy according to New York Heart Association functional classification
R Providência, S Boveda, P Defaye, O Segal… - The American Journal of …, 2016 - Elsevier
We aimed to assess if the outcome of primary prevention implantable cardioverter
defibrillators (ICDs) without cardiac resynchronization therapy is dependent on New York …
defibrillators (ICDs) without cardiac resynchronization therapy is dependent on New York …
[HTML][HTML] Predicting early mortality among implantable defibrillator patients treated with cardiac resynchronization therapy
DAMJ Theuns, N Van Boven, BA Schaer… - Journal of cardiac …, 2019 - Elsevier
Background The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in
patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have …
patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have …
Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy
S Barra, KL Looi, PR Gajendragadkar, FZ Khan… - EP …, 2016 - academic.oup.com
Abstract Aims The Goldenberg risk score, comprising five clinical risk factors (New York
Heart Association class> 2, atrial fibrillation, QRS duration> 120 ms, age> 70 years, and …
Heart Association class> 2, atrial fibrillation, QRS duration> 120 ms, age> 70 years, and …
Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?
Determinants of worse prognosis in patients with cardiac res... : Journal of Cardiovascular
Medicine Determinants of worse prognosis in patients with cardiac resynchronization therapy …
Medicine Determinants of worse prognosis in patients with cardiac resynchronization therapy …
Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients
KC Bilchick, Y Wang, JP Curtis, A Cheng… - American heart …, 2020 - Elsevier
Background Patients with heart failure having a low expected probability of arrhythmic death
may not benefit from implantable cardioverter defibrillators (ICDs). Objective The objective …
may not benefit from implantable cardioverter defibrillators (ICDs). Objective The objective …
Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study
Background Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in
selected heart failure patients, but decision-making regarding selection of CRT-defibrillator …
selected heart failure patients, but decision-making regarding selection of CRT-defibrillator …
[HTML][HTML] Primary prevention implantable cardioverter defibrillator in patients with reduced ejection fraction: for ischemic or non-ischemic cardiomyopathy or both?
AF Barakat, AN Mahmoud… - Journal of Thoracic …, 2017 - ncbi.nlm.nih.gov
Despite the potential criticism that might arise from analyzing trial-level data, rather than
patient-level data, and that the trials included in this study span across a decade, this meta …
patient-level data, and that the trials included in this study span across a decade, this meta …